Antipsychotics, mood stabilizers, etc.
Pre-clinicalRecruiting 0 watching 0 views this week💤 Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Adolescent
Conditions
Adolescent, Bipolar Depression, tDCS, Primary Somatosensory Cortex, Bipolar Disorder Depression
Trial Timeline
Sep 16, 2025 → Dec 31, 2027
NCT ID
NCT07246044About Antipsychotics, mood stabilizers, etc.
Antipsychotics, mood stabilizers, etc. is a pre-clinical stage product being developed by Brain Biotech for Adolescent. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07246044. Target conditions include Adolescent, Bipolar Depression, tDCS.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07246044 | Pre-clinical | Recruiting |
| NCT05498441 | Pre-clinical | UNKNOWN |
Competing Products
8 competing products in Adolescent
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Lorcaserin | Eisai | Phase 1 | 33 |
| RSS0343 Tabella | Jiangsu Hengrui Medicine | Phase 2 | 52 |
| Exenatide Once Weekly + Placebo | AstraZeneca | Phase 3 | 77 |
| Placebo + IBI362 | Innovent Biologics | Phase 3 | 76 |
| IBI362 + IBI362 placebo | Innovent Biologics | Phase 1 | 32 |
| voclosporin | Aurinia Pharmaceuticals | Phase 3 | 72 |
| Voclosporin + Placebo Oral Capsule | Aurinia Pharmaceuticals | Phase 3 | 72 |
| rizatriptan benzoate | Organon | Phase 3 | 72 |